GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration.
about
Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degenerationGenetics of age-related macular degeneration (AMD).Genetics and genetic testing for age-related macular degeneration.Identification of novel alleles associated with insulin resistance in childhood obesity using pooled-DNA genome-wide association study approach.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.
P2860
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
GWAS study using DNA pooling s ...... -related macular degeneration.
@en
GWAS study using DNA pooling s ...... -related macular degeneration.
@nl
type
label
GWAS study using DNA pooling s ...... -related macular degeneration.
@en
GWAS study using DNA pooling s ...... -related macular degeneration.
@nl
prefLabel
GWAS study using DNA pooling s ...... -related macular degeneration.
@en
GWAS study using DNA pooling s ...... -related macular degeneration.
@nl
P2093
P2860
P50
P356
P1433
P1476
GWAS study using DNA pooling s ...... -related macular degeneration.
@en
P2093
Andrea J Richardson
Anneke I den Hollander
Carel B Hoyng
Dzenita Smailhodzic
Eiko K de Jong
Kathryn P Burdon
Laura Lorés-Motta
Lebriz Altay
P2860
P2888
P356
10.1038/SREP37924
P407
P577
2016-11-28T00:00:00Z